Navigation Links
Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
Date:11/21/2008

New hire brings over 20 years of commercial life sciences sales experience to Cyntellect

SAN DIEGO, Nov. 21 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and commercialization of live cell analysis and manipulation systems, announced today that it has appointed Andre Lubarsky as the Company's Director of Sales - North America. Andre will be responsible for the sales of Cyntellect's cell purification and cell health products in the life sciences research market. He joins Cyntellect with an extensive sales and sales management background at leading life sciences companies including BD Biosciences, Applied Imaging and Leica Inc.

"Andre's extensive sales and sales management experience in the life sciences research market, particularly in the cellular bioassay and analysis markets, will accelerate the commercialization of Cyntellect's products for applications in biopharmaceutical cell line development, cell line development for drug discovery and research including key applications utilizing stem cells and primary cells," said Fred Koller, Ph.D., Cyntellect's President and Chief Executive Officer. "We are very pleased to have someone of Andre's experience and customer-focused nature join the Cyntellect commercial team."

Andre comes to Cyntellect from BD Biosciences Bioimaging Systems where he filled the role of Director of Sales - North America. Prior to that, he was National Imaging Sales Manager at McBain Instruments in Chatsworth, CA. Andre joined McBain Instruments from a role as Senior Sales Manager at Applied Imaging in Santa Clara, CA. Andre's prior experience included other executive sales management positions with Leica Inc., Bio-Rad Laboratories and Cambridge Instruments. Andre graduated in Biological Sciences from the University of California - San Diego.

About Cyntellect

Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at www.cyntellect.com.


'/>"/>
SOURCE Cyntellect, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells
2. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
3. Cyntellect to Collaborate With the Burnham Institute for Medical Research
4. InCode BioPharmaceutics Appoints New President and CEO
5. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
6. GeneNews appoints Canadian Colorectal Cancer Advisory Board
7. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
8. TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
9. Accumetrics Appoints John J. Young, MD Chief Medical Officer
10. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
11. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):